Search

Current filters: Treatment, Research summary, English

Revisiting TDF + FTC as a potential preventive for COVID-19

From TreatmentUpdate 238
2020, CATIE
Research summary - Webpage

Triple therapy with interferon-beta + Kaletra + ribavirin

From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage

Kaletra—from HIV to SARS to COVID-19

From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage

Kaletra disappointing in people severely ill with COVID-19

2020, CATIE
Research summary - Webpage

Canadian trends in hepatitis C virus treatment for people co-infected with HCV and HIV

2020, CATIE
Research summary - Webpage

Might cost issues affect the success of HIV care programs in the future?

2020, CATIE
Research summary - Webpage

Improved health when treatment for both hepatitis C and opioid use disorder are offered

2020, CATIE
Research summary - Webpage

Managing medicines may become more difficult as some HIV-positive people age

2020, CATIE
Research summary - Webpage

Hepatitis C treatment in harm reduction programs for people who use drugs

From Prevention in Focus - Spring 2020
2020, CATIE
Research summary - Webpage

Dolutegravir and TAF or TDF—safety issues and weight gain

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage